Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Better MedSpa vs Framework

Better MedSpa
Graded #402

Higher grade

vs+5.600000000000001
Framework
Graded #485

Lower grade

The verdict

Better MedSpa takes it — 57.2/100 to 51.6/100.

Better MedSpa grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Better MedSpa is a physician-led Chicago (Lincoln Park) practice offering medical weight loss and body contouring, with telehealth across Illinois.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationBetter MedSpa +16
56
40
Clinical oversightBetter MedSpa +5
77
72
Labs & monitoringEven
52
52
FulfillmentBetter MedSpa +3
60
57
Contract termsBetter MedSpa +14
55
41
Better MedSpa · left barFramework · right bar

The numbers

MetricBetter MedSpaFramework
WeighScore57.2/10051.6/100
GradeCC
Scorecard rank#402#485
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
Coverage1 stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Better MedSpa

Graded #402 · C

Strengths

  • Broad menu: semaglutide, tirzepatide, and liraglutide
  • Both oral and injectable formulations offered
  • Physician-led; medical director Dr. Brett Brechner, DO
  • Both in-person Chicago visits and statewide telehealth
  • Doorstep delivery throughout Illinois

Where it loses points

  • Telehealth limited to Illinois only
  • No pricing published online
  • Compounded vs brand formulation not specified
  • Med-spa positioning blends weight loss with aesthetics
Framework

Graded #485 · C

Strengths

  • The compounding pharmacy partner is named, which most of this field does not do
  • Treatment selection is doctor-guided rather than a fixed product menu
  • US-licensed clinicians and a 503A pharmacy pathway

Where it loses points

  • No monthly medication price is published: the tirzepatide and semaglutide pages carry no price at all, and the homepage advertises a per-week figure for 'GLP-1s' generally rather than a rate for either drug
  • The only drug-specific prices anywhere on the site sit on a legacy page — semaglutide at $349 per three months and tirzepatide at $549 per three months
  • A '$75/month with 3-month package' figure is footnoted as a promotion for new GLP-1 users only
  • Different landing pages advertise different per-week rates, $25 on one and $19 on another
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard